|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/27 | (2006.01) |
| A61P 25/08 | (2006.01) |
| (11) | Number of the document | 1809273 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05810288.0 |
| Date of filing the European patent application | 2005-09-15 | |
| (97) | Date of publication of the European application | 2007-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2010-04-14 |
| (46) | Date of publication of the claims translation | 2010-08-25 |
| (86) | Number | PCT/US2005/032861 |
| Date | 2005-09-15 |
| (87) | Number | WO 2006/033947 |
| Date | 2006-03-30 |
| (30) | Number | Date | Country code |
| 610276 P | 2004-09-16 | US | |
| 698625 P | 2005-07-12 | US | |
| 707242 P | 2005-08-11 | US |
| (72) |
CHOI, Yong Moon, US
GORDON, Robert, US
NOVAK, Gerald P., US
PLATA-SALAMAN, Carlos R., US
TWYMAN, Roy E, US
WHITE, H. Steve, US
ZHAO, Boyu, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 2-Fenil-1,2-etandiol-(di)karbamatų panaudojimas epileptogenezės gydymui |
| USE OF 2-PHENYL-1,2-ETHANEDIOL-(DI)CARBAMATES FOR TREATING EPILEPTOGENESIS |
| Payment date | Validity (years) | Amount | |
| 2010-08-12 | 6 | 480.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2010-09-15 |